Literature DB >> 28602741

Disease resistance and response against Vibrio anguillarum intestinal infection in European seabass (Dicentrarchus labrax) fed low fish meal and fish oil diets.

S Torrecillas1, M J Caballero1, D Mompel1, D Montero1, M J Zamorano1, L Robaina1, F Rivero-Ramírez1, V Karalazos2, S Kaushik1, M Izquierdo1.   

Abstract

The aim of this study was to assess the effects of low levels of dietary fish meal (FM) and fish oil (FO) on disease resistance and gut associated lymphoid tissue (GALT) response after an experimental intestinal infection with V. anguillarum in European sea bass (Dicentrarchus labrax) For that purpose, sea bass juveniles were fed one of four diets containing combined levels of FO and FM as follows: 20%FM/6%FO, 20%FM/3%FO, 5%FM/6%FO and 5%FM/3%FO during 153 days. At the end of the feeding trial, fish were subjected to either an in vivo exposure to a sub-lethal dose of V. anguillarum via anal inoculation or to an ex vivo exposure to V. anguillarum. Additionally, inducible nitric oxide synthase (iNOS) and tumor necrosis factor α (TNFα) gut patterns of immunopositivity were studied. Growth performance was affected by dietary FM level, however ex vivo gut bacterial translocation rates and survival after the in vivo challenge test were affected by dietary FO level. After 5 months of feeding, low dietary FM levels led to a posterior gut up-regulation of interleukin-1β (IL-1β) and TNFα, major histocompatibility complex-II (MHCII) and cyclooxygenase-2 (COX2), which in turn reduced the gut associated lymphoid tissue (GALT) capacity of response after 24 h post infection and conditioned European sea bass capacity to recover gut homeostasis 7 days post infection. Immunoreactivity to anti-iNOS and anti-TNFα presented a gradient of increased immunopositivity towards the anus, regardless of the dietary FM/FO fed. Strong positive anti-TNFα isolated enterocytes were observed in the anterior gut in relation to low levels of dietary FM/FO. Submucosa and lamina propria immunoreactivity grade was related to the amount of leucocyte populations infiltrated and goblet cells presented immunopositivity to anti-iNOS but not to anti-TNFα. Thus, reducing FO content from 6% to a 3% by VO in European sea bass diets increases ex vivo and in vivo gut bacterial translocation rates, whereas reducing FM content from 20% down to 5% up-regulates the expression of several posterior gut inflammation-related genes conditioning fish growth and GALT capacity of response after bacterial infection.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alternative meals; Alternative oils; European sea bass; GALT; Gut bacterial translocation

Mesh:

Substances:

Year:  2017        PMID: 28602741     DOI: 10.1016/j.fsi.2017.06.022

Source DB:  PubMed          Journal:  Fish Shellfish Immunol        ISSN: 1050-4648            Impact factor:   4.581


  9 in total

Review 1.  Mucosal immunoglobulins of teleost fish: A decade of advances.

Authors:  Irene Salinas; Álvaro Fernández-Montero; Yang Ding; J Oriol Sunyer
Journal:  Dev Comp Immunol       Date:  2021-03-27       Impact factor: 3.605

2.  Intestinal Explant Cultures from Gilthead Seabream (Sparus aurata, L.) Allowed the Determination of Mucosal Sensitivity to Bacterial Pathogens and the Impact of a Plant Protein Diet.

Authors:  David Sánchez Peñaranda; Christine Bäuerl; Ana Tomás-Vidal; Miguel Jover-Cerdá; Guillem Estruch; Gaspar Pérez Martínez; Silvia Martínez Llorens
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

3.  Nutrient Digestibility, Growth, Mucosal Barrier Status, and Activity of Leucocytes From Head Kidney of Atlantic Salmon Fed Marine- or Plant-Derived Protein and Lipid Sources.

Authors:  Solveig L Sørensen; Youngjin Park; Yangyang Gong; Ghana K Vasanth; Dalia Dahle; Kjetil Korsnes; Tran Ha Phuong; Viswanath Kiron; Sjur Øyen; Karin Pittman; Mette Sørensen
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

4.  Dynamic Transcriptomic Profiling During Liver Development in Schizothorax Prenanti.

Authors:  Jiahui Ni; Peng Zhu; Qilang Mo; Wei Luo; Zongjun Du; Jun Jiang; Song Yang; Liulan Zhao; Quan Gong; Yan Wang
Journal:  Front Physiol       Date:  2022-07-11       Impact factor: 4.755

5.  Assessment of Conventional and Low Gossypol Cottonseed Meal as Alternative Protein Sources in Low-Fishmeal Diets of Hybrid Grouper (Epinephelus fuscoguttatus× Epinephelus lanceolatus): Growth, Feed Utilization, Gut Histology, and Immunity.

Authors:  Misbah Irm; Bo Ye; Xiaoyi Wu; Lina Geng; Qinxiao Cai; Lu Zhang; Haoyun Zhai; Zhiyu Zhou
Journal:  Animals (Basel)       Date:  2022-07-26       Impact factor: 3.231

Review 6.  Effects of intestinal microbiota on physiological metabolism and pathogenicity of Vibrio.

Authors:  Han Sun; Changliang Zhu; Xiaodan Fu; Shakir Khattak; Jingyu Wang; Zhihao Liu; Qing Kong; Haijin Mou; Francesco Secundo
Journal:  Front Microbiol       Date:  2022-08-23       Impact factor: 6.064

7.  Long-term feeding with high plant protein based diets in gilthead seabream (Sparus aurata, L.) leads to changes in the inflammatory and immune related gene expression at intestinal level.

Authors:  Guillem Estruch; Maria Carmen Collado; Raquel Monge-Ortiz; Ana Tomás-Vidal; Miguel Jover-Cerdá; David S Peñaranda; Gaspar Pérez Martínez; Silvia Martínez-Llorens
Journal:  BMC Vet Res       Date:  2018-10-03       Impact factor: 2.741

8.  Characterization of IL-22 Bioactivity and IL-22-Positive Cells in Grass Carp Ctenopharyngodon idella.

Authors:  Yibin Yang; Junya Wang; Jiawen Xu; Qin Liu; Zixuan Wang; Xiaozhen Zhu; Xiaohui Ai; Qian Gao; Xinhua Chen; Jun Zou
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

9.  Hermetia illucens and Poultry by-Product Meals as Alternatives to Plant Protein Sources in Gilthead Seabream (Sparus aurata) Diet: A Multidisciplinary Study on Fish Gut Status.

Authors:  Basilio Randazzo; Matteo Zarantoniello; Gloriana Cardinaletti; Roberto Cerri; Elisabetta Giorgini; Alessia Belloni; Michela Contò; Emilio Tibaldi; Ike Olivotto
Journal:  Animals (Basel)       Date:  2021-03-04       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.